N-Cadherin antibody (Cytoplasmic Domain)
Quick Overview for N-Cadherin antibody (Cytoplasmic Domain) (ABIN6295444)
Target
See all N-Cadherin (CDH2) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- Cytoplasmic Domain
-
Purpose
- Mouse anti-Human/Mouse/Rat N-Cadherin Antibody / CDH2 [Sodium Azide Free]
-
Specificity
- Cytoplasmic
-
Purification
- A human partial recombinant protein corresponding to the CDH2/NCAD cytoplasmic domain was used as the immunogen for this N-Cadherin antibody.
-
Immunogen
- A human partial recombinant protein corresponding to the CDH2/NCAD cytoplasmic domain was used as the immunogen for this N-Cadherin antibody.
-
-
-
-
Application Notes
-
FACS: 0.5-1 μg/10^6 cells in 0.1ml
IF: 1-2 μg/mL
WB: 0.5-1 μg/mL -
Restrictions
- For Research Use only
-
-
-
Buffer
- In 1X PBS, BSA free, sodium azide free
-
Preservative
- Azide free
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- 2-8°C. The azide-free format should be aliquoted and stored at -20°C or colder.
-
-
- N-Cadherin (CDH2) (Cadherin 2 (CDH2))
-
Alternative Name
- Cadherin-2
-
Background
-
Target Description: Recognizes a protein of ~140 kDa, identified as N-Cadherin (NCAD), also known as CDH2 and CD325. NCAD is a member of the Cadherin superfamily, and consists of five extracellular repeats, a transmembrane domain and a cytoplasmic domain. NCAD/CD325 deficient mice die at day 10 of gestation and embryos display major heart defects and malformed neural tubes and somites. Consistent with this, the protein has been implicated in several aspects of cardiac development including the precardiac mesoderm, establishment of left-right symmetry and cardiac looping morphogenesis. Furthermore, it is normally involved in inducing cell cycle arrest and its expression is frequently deregulated in cancer cells. Studies have linked N-cadherin to cancer metastasis by showing the aggressive tumor cells had preferentially turned on N-cadherin as opposed to E- or P-cadherin.
Gene Symbol: CDH2///CDHN///NCAD
-
Gene ID
- 1000
-
UniProt
- P19022
-
Pathways
- Regulation of Muscle Cell Differentiation, Cell-Cell Junction Organization, Synaptic Membrane
Target
-